Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G
Gastroenterology. 2013 May 15;145(3):647-57.e15. doi: 10.1053/j.gastro.2013.05.011
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours.
Galon J
J Pathol. 232(2):199-209. doi: 10.1002/path.4287
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
Di Caro G
Clin Cancer Res. 2014 Feb 12;20(8):2147-58. doi: 10.1158/1078-0432.CCR-13-2590
The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
Erreni M
J Immunol. 2015 Dec 16;196(2):902-14. doi: 10.4049/jimmunol.1501335
Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N
World J Gastroenterol. 22(18):4466-83. doi: 10.3748/wjg.v22.i18.4466
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.
Cereda M
Nat Commun. 2016 Jul 5;7:12072. doi: 10.1038/ncomms12072
Tumour-associated macrophages as treatment targets in oncology.
Mantovani A
Nat Rev Clin Oncol. 2017 Jan 24;14(7):399-416. doi: 10.1038/nrclinonc.2016.217
Hereditary or sporadic polyposis syndromes.
Basso G
Best Pract Res Clin Gastroenterol. 2017 Jun 6;31(4):409-417. doi: 10.1016/j.bpg.2017.05.011
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.
Malesci A
Oncoimmunology. 2017 Jul 12;6(12):e1342918. doi: 10.1080/2162402X.2017.1342918
Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
Grizzi F
Inflamm Res. 2018 Jan 10;67(5):375-389. doi: 10.1007/s00011-017-1128-1